These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 8420607)
1. Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer. Hsing AW; Comstock GW Cancer Epidemiol Biomarkers Prev; 1993; 2(1):27-32. PubMed ID: 8420607 [TBL] [Abstract][Full Text] [Related]
2. Influence of radical prostatectomy on serum hormone levels. Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896 [TBL] [Abstract][Full Text] [Related]
3. Early and late long-term effects of vasectomy on serum testosterone, dihydrotestosterone, luteinizing hormone and follicle-stimulating hormone levels. Mo ZN; Huang X; Zhang SC; Yang JR J Urol; 1995 Dec; 154(6):2065-9. PubMed ID: 7500459 [TBL] [Abstract][Full Text] [Related]
4. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial. Chen C; Weiss NS; Stanczyk FZ; Lewis SK; DiTommaso D; Etzioni R; Barnett MJ; Goodman GE Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1410-6. PubMed ID: 14693730 [TBL] [Abstract][Full Text] [Related]
5. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia. Cochran RC; Ewing LL; Niswender GD Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603 [TBL] [Abstract][Full Text] [Related]
6. Hormonal predictors of prostate cancer. Sofikerim M; Eskicorapci S; Oruç O; Ozen H Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161 [TBL] [Abstract][Full Text] [Related]
7. Prediagnostic serum hormones and the risk of prostate cancer. Nomura A; Heilbrun LK; Stemmermann GN; Judd HL Cancer Res; 1988 Jun; 48(12):3515-7. PubMed ID: 3370644 [TBL] [Abstract][Full Text] [Related]
8. The endocrine profiles in men with localized and locally advanced prostate cancer treated with radical prostatectomy. Heracek J; Urban M; Sachova J; Kuncova J; Eis V; Mandys V; Hampl R; Starka L Neuro Endocrinol Lett; 2007 Feb; 28(1):45-51. PubMed ID: 17277727 [TBL] [Abstract][Full Text] [Related]
9. Control of prostate growth. Coffey DS; Isaacs JT Urology; 1981 Mar; 17(Suppl 3):17-24. PubMed ID: 6163242 [No Abstract] [Full Text] [Related]
10. High-grade prostate cancer is associated with low serum testosterone levels. Schatzl G; Madersbacher S; Thurridl T; Waldmüller J; Kramer G; Haitel A; Marberger M Prostate; 2001 Apr; 47(1):52-8. PubMed ID: 11304729 [TBL] [Abstract][Full Text] [Related]
11. Serum androgens: associations with prostate cancer risk and hair patterning. Demark-Wahnefried W; Lesko SM; Conaway MR; Robertson CN; Clark RV; Lobaugh B; Mathias BJ; Strigo TS; Paulson DF J Androl; 1997; 18(5):495-500. PubMed ID: 9349747 [TBL] [Abstract][Full Text] [Related]
12. [Serum levels of gonadotrophins, testosterone and estradiol in acne vulgaris]. Krause W Hautarzt; 1977 Jul; 28(7):368-70. PubMed ID: 142752 [TBL] [Abstract][Full Text] [Related]
14. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Dorgan JF; Longcope C; Stephenson HE; Falk RT; Miller R; Franz C; Kahle L; Campbell WS; Tangrea JA; Schatzkin A Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):533-9. PubMed ID: 8827358 [TBL] [Abstract][Full Text] [Related]
15. Testosterone levels in benign prostatic hypertrophy and prostate cancer. Mearini L; Costantini E; Zucchi A; Mearini E; Bini V; Cottini E; Porena M Urol Int; 2008; 80(2):134-40. PubMed ID: 18362481 [TBL] [Abstract][Full Text] [Related]
16. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women. Usuki S; Kondoh K; Kubo T J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439 [TBL] [Abstract][Full Text] [Related]
17. Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch-Japanese case-control study. de Jong FH; Oishi K; Hayes RB; Bogdanowicz JF; Raatgever JW; van der Maas PJ; Yoshida O; Schroeder FH Cancer Res; 1991 Jul; 51(13):3445-50. PubMed ID: 1711411 [TBL] [Abstract][Full Text] [Related]
18. Serum levels of hypothalamic-pituitary-testicular axis hormones in men with or without prostate cancer or atypical small acinar proliferation. Schmitt Cda S; Rhoden EL; Almeida GL Clinics (Sao Paulo); 2011; 66(2):183-7. PubMed ID: 21484031 [TBL] [Abstract][Full Text] [Related]
20. Investigative clinical study on prostate cancer part VII: prolactin and the pituitary-testis-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population. Porcaro AB; Ghimenton C; Petrozziello A; Migliorini F; Romano M; Sava T; Caruso B; Cocco C; Antoniolli SZ; Lacola V; Rubilotta E; Monaco C; Comunale L Anticancer Res; 2011 Nov; 31(11):3913-20. PubMed ID: 22110219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]